...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Precedence in Gene Therapy Pricing

$5,000 is the minimum cost per patient/year assumed in the Beacon report....(page 19).  That works out to $13.70 per pill assuming a daily dose or about $417 per month.  I recalled a $5 per pill reference, but I might have been mistaken. 

The report expresses the view that this assumption is "very conservative".  

Share
New Message
Please login to post a reply